Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers

Journal of Alzheimer's Disease

Volumn 24, Issue 3, 2011, Pages 495-506

  Schöll, Michael ^a   Almkvist, Ove ^a,b   Bogdanovic, Nenad ^a   Wall, Anders ^c   Lngström, Bengt ^d   Viitanen, Matti ^a   Nordberg, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c BIACORE AB   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Early onset familial Alzheimer's disease; FDG; longitudinal studies; neuritic plaques; neurofibrillary tangles; postitron emission tomography; postmortem pathology; presenilin 1

Indexed keywords

PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; POSTERIOR CINGULATE; PRIORITY JOURNAL; SENILE PLAQUE; TEMPORAL CORTEX;

EID: 79957877195     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-101563     Document Type: Article

References (36)

1. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Dasilva HAR, Haines JL, Pericakvance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, Stgeorgehyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimers disease. Nature 375, 754-760.
2. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu YH, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimers disease locus. Science 269, 973-977.
3. Goate A, Chartierharlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericakvance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimers disease. Nature 349, 704-706. (Pubitemid 21912142)
4. Haltia M, Viitanen M, Sulkava R, Ala-Hurula V, Poyhonen M, Goldfarb L, Brown P, Levy E, Houlden H, Crook R, et al. (1994) Chromosome 14-encoded Alzheimers disease: genetic and clinicopathological description. Ann Neurol 36, 362-367. (Pubitemid 24280057)
5. Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Langstrom B, Nordberg A (2008) PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29, 1456-1465.
6. Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, Langstrom B, Lannfelt L, Graff C, Nordberg A (2009) Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2009.08.016
7. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multipletime uptake data. J Cereb Blood Flow Metab 3, 1-7. (Pubitemid 13129630)
8. Minoshima S, Frey KA, Foster NL, Kuhl DE (1995) Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 19, 541-547.
9. Lezak M (2004) Neuropsychological Assessment 4th Edn, Oxford University Press, New York, Oxford.
10. Lezak M (1983) Neuropsychological Assessment 2nd Edn., Oxford University Press, New York, Oxford.
11. Rey AL (1964) Examen Clinique en Psychologie. Presses Universitaires de France, Paris.
12. Bogdanovic N, Morris J (1995) Neuropathological diagnostic criteria for brain banking. In Biomedical and Health Research Series, IOS Press, pp. 20-29.
13. Corder EH, Woodbury MA, Volkmann I, Madsen DK, Bogdanovic N, Winblad B (2000) Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging. Exp Gerontol 35, 851-864.
14. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
15. Bergman I, BlombergM, Almkvist O (2007) The importance of impaired physical health and age in normal cognitive aging. Scand J Psychol 48, 115-125.
16. Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimers disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32, 486-510. (Pubitemid 40591181)
17. Kennedy AM, Newman SK, Frackowiak RS, Cunningham VJ, Roques P, Stevens J, Neary D, Bruton CJ, Warrington EK, Rossor MN (1995) Chromosome 14 linked familial Alzheimers disease. A clinico-pathological study of a single pedigree. Brain 118(Pt 1), 185-205.
18. Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, Cunningham VJ, Rossor MN (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimers disease. Neurosci Lett 186, 17-20.
19. Pietrini P, Azari NP, Grady CL, Salerno JA, Gonzales-Aviles A, Heston LL, Pettigrew KD, Horwitz B, Haxby JV, Schapiro MB(1993) Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimers disease: a longitudinal evaluation. Dementia 4, 94-101. (Pubitemid 23125357)
20. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimers disease. J Nucl Med 47, 1778-1786. (Pubitemid 47553729)
21. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM (2002) Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimers disease treatment studies. Am J Psychiatry 159, 738-745. (Pubitemid 34465046)
22. Almkvist O, Axelman K, Basun H, Jensen M, Viitanen M, Wahlund LO, Lannfelt L (2003) Clinical findings in nondemented mutation carriers predisposed to Alzheimers disease: a model of mild cognitive impairment. Acta Neurol Scand Suppl 179, 77-82.
23. Bogdanovic N, Corder E, Lannfelt L, Winblad B (2002) APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimers disease. J Cell Mol Med 6, 199-214. (Pubitemid 44133969)
24. Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS (1999) Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord 13, 226-231. (Pubitemid 30011381)
25. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27, 6174-6184. (Pubitemid 46890033)
26. Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T (1999) Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med 5, 560-564. (Pubitemid 29220216)
27. Pakkenberg B, Gundersen HJ (1997) Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384, 312-320. (Pubitemid 27282046)
28. Mega MS, Chen SS, Thompson PM, Woods RP, Karaca TJ, Tiwari A, Vinters HV, Small GW, Toga AW (1997) Mapping histology to metabolism: coregistration of stained wholebrain sections to premortem PET in Alzheimers disease. Neuroimage 5, 147-153. (Pubitemid 27481519)
29. Vukovich R, Perneczky R, Drzezga A, Forstl H, Kurz A, Riemenschneider M (2009) Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimers disease. Dement Geriatr Cogn Disord 27, 474-480.
30. Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A (2011) Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first 11C-PIB PET AD patient. Brain 134(Pt 1), 301-317.
31. Mielke R, Kittner B, Ghaemi M, Kessler J, Szelies B, Herholz K, Heiss WD (1996) Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia. J Neurol Sci 141, 59-64. (Pubitemid 26297731)
32. Welander H, Franberg J, Graff C, Sundstrom E, Winblad B, Tjernberg LO (2009) Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains. J Neurochem 110, 697-706.
33. Mann DM, Iwatsubo T, Cairns NJ, Lantos PL, Nochlin D, Sumi SM, Bird TD, Poorkaj P, Hardy J, Hutton M, Prihar G, Crook R, Rossor MN, Haltia M (1996) Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimers disease: predominance of Abeta42(43). Ann Neurol 40, 149-156.
34. Mann DM, Iwatsubo T, Ihara Y, Cairns NJ, Lantos PL, Bogdanovic N, Lannfelt L, Winblad B, Maat-Schieman ML, Rossor MN (1996) Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimers disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 148, 1257-1266.
35. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimertype pathologic changes in the brain. Arch Neurol 66, 382-389.
36. Hellström-Lindahl E, Viitanen M, Marutle A (2009) Comparison of Abeta levels in the brain of familial and sporadic Alzheimers disease. Neurochem Int 55, 243-252.